Page last updated: 2024-08-16

thalidomide and myelin basic protein

thalidomide has been researched along with myelin basic protein in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brook, GA; Buss, A; Deumens, R; Geoghegan, L; Honig, WH; Joosten, EA; Kern, N; Koopmans, GC; Myint, AM; Noth, J	1

Other Studies

1 other study(ies) available for thalidomide and myelin basic protein

Article	Year
Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury. Experimental neurology, 2009, Volume: 216, Issue:2 Topics: Animals; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-1beta; Locomotion; Male; Myelin Basic Protein; Nerve Regeneration; Neurofilament Proteins; Phosphodiesterase Inhibitors; Psychomotor Performance; Rats; Rats, Inbred Lew; Recovery of Function; Rolipram; Spinal Cord Injuries; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha	2009

Article

Year

Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury.

Experimental neurology, 2009, Volume: 216, Issue:2

Topics: Animals; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-1beta; Locomotion; Male; Myelin Basic Protein; Nerve Regeneration; Neurofilament Proteins; Phosphodiesterase Inhibitors; Psychomotor Performance; Rats; Rats, Inbred Lew; Recovery of Function; Rolipram; Spinal Cord Injuries; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha

2009